Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.4878
-0.0152 (-3.02%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Oragenics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.86 | 4.4 | 0.86 | 3.48 | 11.43 | 27.27 |
Short-Term Investments | - | 4 | - | - | 0.02 | - |
Cash & Short-Term Investments | 3.86 | 8.4 | 0.86 | 3.48 | 11.44 | 27.27 |
Cash Growth | 95.78% | 871.25% | -75.17% | -69.56% | -58.03% | 54.57% |
Other Receivables | - | 0.05 | - | - | - | 0.01 |
Receivables | - | 0.05 | - | - | - | 0.01 |
Prepaid Expenses | 1.63 | 1.61 | 0.61 | 0.38 | 0.37 | 0.43 |
Other Current Assets | - | - | - | - | 2.47 | - |
Total Current Assets | 5.49 | 10.07 | 1.47 | 3.87 | 14.29 | 27.71 |
Property, Plant & Equipment | - | - | - | 0.01 | 0.47 | 0.52 |
Long-Term Deferred Charges | - | - | - | 1.09 | - | - |
Total Assets | 5.49 | 10.07 | 1.47 | 4.97 | 14.76 | 28.23 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.82 | 1.56 | 1.36 | 1.24 | 0.25 | 0.85 |
Accrued Expenses | - | - | - | 0.23 | 0.88 | 0.09 |
Short-Term Debt | - | 0.23 | 0.33 | 0.31 | 0.27 | 0.3 |
Current Portion of Leases | - | - | - | 0.01 | 0.2 | 0.19 |
Total Current Liabilities | 1.82 | 1.79 | 1.68 | 1.8 | 1.6 | 1.45 |
Long-Term Leases | - | - | - | - | 0.15 | 0.3 |
Total Liabilities | 1.82 | 1.79 | 1.68 | 1.8 | 1.75 | 1.74 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 235.02 | 234.91 | 216.57 | 207.79 | 196.98 | 195.1 |
Retained Earnings | -231.36 | -226.63 | -216.79 | -206.22 | -185.56 | -171.27 |
Total Common Equity | 3.67 | 8.28 | -0.21 | 1.58 | 11.42 | 23.83 |
Shareholders' Equity | 3.67 | 8.28 | -0.21 | 3.17 | 13.01 | 26.49 |
Total Liabilities & Equity | 5.49 | 10.07 | 1.47 | 4.97 | 14.76 | 28.23 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 0.23 | 0.33 | 0.32 | 0.62 | 0.8 |
Net Cash (Debt) | 3.86 | 8.17 | 0.54 | 3.16 | 10.82 | 26.47 |
Net Cash Growth | - | 1423.81% | -83.03% | -70.79% | -59.12% | 58.11% |
Net Cash Per Share | 0.96 | 3.79 | 2.43 | 42.16 | 161.57 | 408.69 |
Filing Date Shares Outstanding | 4.51 | 4.34 | 0.72 | 0.15 | 0.07 | 0.06 |
Total Common Shares Outstanding | 4.51 | 4.27 | 0.42 | 0.1 | 0.07 | 0.06 |
Working Capital | 3.67 | 8.28 | -0.21 | 2.07 | 12.69 | 26.26 |
Book Value Per Share | 0.81 | 1.94 | -0.51 | 15.34 | 169.18 | 368.55 |
Tangible Book Value | 3.67 | 8.28 | -0.21 | 1.58 | 11.42 | 23.83 |
Tangible Book Value Per Share | 0.81 | 1.94 | -0.51 | 15.34 | 169.18 | 368.55 |
Machinery | - | - | - | - | 1 | 1.18 |
Leasehold Improvements | - | - | - | - | 0.49 | 0.49 |